Uppsala Reports editor
@UMCGlobalSafety
Adverse effects to medicines are not just physical in nature, but can manifest as behavioural side-effects too. How do we diagnose and treat these complex ADRs?
Drug-induced impulse control disorders have the potential to negatively impact overall quality of life, but are especially hard to identify, diagnose, and treat. In the latest Drug Safety Matters podcast, Michele Fusaroli of the University of Bologna describes which types of medicines are most likely to cause these impulsive behaviours, and how listening to patient stories can be a huge help in their detection and treatment.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
Uppsala Reports editor
@UMCGlobalSafety
Online psychedelic forums hold untapped safety data. AI analysis of user narratives could help pharmacovigilance systems detect risks missed by traditional reporting.
13 November 2025
An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.
30 March 2026
While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions
18 February 2026